We are live on ! Find out more
Daiwa Securities Group

Daiwa Securities Group Portfolio holdings

AUM $34.8B
1-Year Est. Return 20.7%
This Fund
S&P 500
This Quarter Est. Return
+7.67%
1 Year Est. Return
+20.7%
3 Year Est. Return
+66.64%
5 Year Est. Return
+79.21%
10 Year Est. Return
+192.59%
AUM
$14.4B
AUM Growth
+$1.36B
Cap. Flow
+$273M
Cap. Flow %
1.9%
Top 10 Hldgs %
37.21%
Holding
1,342
New
30
Increased
738
Reduced
241
Closed
27

Sector Composition

Rank Sector Weight
1 Real Estate 55.05%
2 Technology 11.48%
3 Consumer Discretionary 4.63%
4 Healthcare 4.39%
5 Communication Services 3.94%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
OPTN
1251
DELISTED
OptiNose
OPTN
$1K ﹤0.01%
21
PAHC icon
1252
Phibro Animal Health
PAHC
$1.5B
$1K ﹤0.01%
38
PEPG icon
1253
PepGen
PEPG
$118M
$1K ﹤0.01%
95
PGEN icon
1254
Precigen
PGEN
$1.94B
$1K ﹤0.01%
708
PHAT icon
1255
Phathom Pharmaceuticals
PHAT
$928M
$1K ﹤0.01%
167
PMVP icon
1256
PMV Pharmaceuticals
PMVP
$57.1M
$1K ﹤0.01%
132
PRLD icon
1257
Prelude Therapeutics
PRLD
$375M
$1K ﹤0.01%
104
QSI icon
1258
Quantum-Si Incorporated
QSI
$153M
$1K ﹤0.01%
343
RPTX
1259
DELISTED
Repare Therapeutics
RPTX
$1K ﹤0.01%
127
SGMO
1260
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
$1K ﹤0.01%
498
STOK icon
1261
Stoke Therapeutics
STOK
$1.84B
$1K ﹤0.01%
126
STRO icon
1262
Sutro Biopharma
STRO
$386M
$1K ﹤0.01%
16
TARS icon
1263
Tarsus Pharmaceuticals
TARS
$2.55B
$1K ﹤0.01%
107
TNGX icon
1264
Tango Therapeutics
TNGX
$4.21B
$1K ﹤0.01%
355
VNDA icon
1265
Vanda Pharmaceuticals
VNDA
$304M
$1K ﹤0.01%
191
XERS icon
1266
Xeris Biopharma Holdings
XERS
$1.45B
$1K ﹤0.01%
404
KLRS
1267
Kalaris Therapeutics
KLRS
$80.9M
$1K ﹤0.01%
16
TVRD
1268
Tvardi Therapeutics
TVRD
$20.1M
$1K ﹤0.01%
5
OMGA
1269
DELISTED
Omega Therapeutics, Inc. Common Stock
OMGA
$1K ﹤0.01%
139
PSTX
1270
DELISTED
Poseida Therapeutics, Inc. Common Stock
PSTX
$1K ﹤0.01%
346
PETQ
1271
DELISTED
PetIQ, Inc. Class A Common Stock
PETQ
$1K ﹤0.01%
99
GRTS
1272
DELISTED
Gritstone bio, Inc. Common Stock
GRTS
$1K ﹤0.01%
198
EGRX
1273
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
$1K ﹤0.01%
30
HLTH
1274
DELISTED
Cue Health Inc. Common Stock
HLTH
$1K ﹤0.01%
601
ALPN
1275
DELISTED
Alpine Immune Sciences Inc
ALPN
$1K ﹤0.01%
85

Similar funds

Daiwa Securities Group's Q1 2023 Portfolio in Review

As of Q1 2023, Daiwa Securities Group held 1,342 positions worth $14.4B, up 10% from $13B the previous quarter. Its ten largest holdings account for 37% of the portfolio.

Trading was light in Q1 2023: portfolio turnover was 4.2%. Daiwa Securities Group opened 30 new positions and exited 27, leaving the 1,342-position portfolio largely intact.

By sector, the portfolio is most concentrated in Real Estate at 55% of assets, down from 58% a quarter earlier, followed by Technology and Consumer Discretionary.

  • Daiwa Securities Group's largest Q1 2023 buy was Global X Aging Population ETF: 800,000 shares worth $21.4M.
  • Daiwa Securities Group added most to VICI Properties in Q1 2023, an estimated $79.2M increase.
  • Daiwa Securities Group's biggest Q1 2023 reduction was Lamar Advertising Co, cutting an estimated $81.1M.
  • Daiwa Securities Group fully exited NextEra Energy, Inc. 5.279% Corporate Units in Q1 2023, selling an estimated $15.2M.
  • Daiwa Securities Group's ten largest holdings make up 37% of its $14.4B portfolio in Q1 2023.
  • Daiwa Securities Group opened 30 new positions and closed 27 in Q1 2023.
  • Daiwa Securities Group's portfolio value rose 10% quarter-over-quarter to $14.4B.

Based on Daiwa Securities Group's 13F filing for Q1 2023, filed 2 May 2023.